雅高控股(03313.HK)完成配售4.5億股股份 淨籌4000萬港元
格隆匯 8 月 3日丨雅高控股(03313.HK)發佈公告,配售協議所載的條件已於2020年7月30日獲達成及配售事項已於2020年8月3日根據配售協議的條款完成。合共4.5億股配售股份,佔緊隨完成後公司於公告日期已發行股本約11.81%,已成功按每股配售股份0.09港元的配售價向不少於六名承配人配售。
配售事項的所得款項淨額為約4000萬港元,(i)約1000萬港元擬用作集團的租金、薪金及大理石加工廠的經營成本等一般營運資金;(ii)約3000萬港元擬用於償還集團債務及相關利息成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.